EYEPOINT PHARMACEUTICALS INC (EYPT) Stock Income Statement
NASDAQ:EYPT - Nasdaq - US30233G2093 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 56.04M | 43.27M | 46.02M | 41.40M | 36.94M | |||
| Cost Of Goods | 3.76M | 3.71M | 4.63M | 8.33M | 8.18M | |||
| Gross Profit | 52.28M | 39.56M | 41.39M | 33.08M | 28.76M | |||
| Operating Expenses | 213.65M | 185.41M | 116.45M | 112.01M | 84.04M | |||
| Research and Development | 157.90M | 130.19M | 64.66M | 49.64M | 28.50M | |||
| Selling, General, and Administrative Expenses | 55.76M | 55.23M | 51.79M | 60.32M | 53.08M | |||
| Operating Income | -161.37M | -145.85M | -75.07M | -78.94M | -55.28M | |||
| Interest Income/Expense | 14.68M | 15.07M | 5.70M | -1.06M | -5.21M | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | N/A | |||
| Non Recurring Items | N/A | 0.00 | -1.35M | -22.26M | 2.07M | |||
| Income Before Taxes | -146.69M | -130.78M | -70.71M | -102.25M | -58.42M | |||
| Income Tax | N/A | 90.00K | 83.00K | N/A | N/A | |||
| Net Income | -146.78M | -130.87M | -70.80M | -102.25M | -58.42M | |||
| EBITDA | -159.64M | -144.31M | -74.60M | -76.49M | -52.51M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.41 | -2.32 | -1.82 | -2.74 | -2.03 | |||
| Non GAAP EPS | -2.41 | -2.31 | -1.83 | -2.73 | -2.02 | |||
| Statistics | ||||||||
| Gross Profit Margin | 93.29% | 91.42% | 89.93% | 79.90% | 77.86% | |||
| Profit Margin | -261.91% | -302.43% | -153.84% | -246.98% | -158.15% | |||
| Operating Profit Margin | -287.94% | -337.06% | -163.13% | -190.68% | -149.65% | |||
All data in USD